Importer of Controlled Substances; Notice of Application, 19594 [E9-9778]

Download as PDF pwalker on PROD1PC71 with NOTICES 19594 Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices presentations should attend a prehearing conference to be held at 9:30 a.m. on May 28, 2009 at the U.S. International Trade Commission Building. Oral testimony and written materials to be submitted at the hearing are governed by sections 201.6(b)(2) and 201.13(f) of the Commission’s rules. Written submissions.—Each party is encouraged to submit a prehearing brief to the Commission. The deadline for filing prehearing briefs is May 28, 2009. Parties may also file posthearing briefs. The deadline for filing posthearing briefs is June 8, 2009. In addition, any person who has not entered an appearance as a party to the investigation may submit a written statement of information pertinent to the consideration of market disruption or threat thereof and/or remedy on or before June 8, 2009. Parties may submit final comments on market disruption on or before June 16, 2009 and on remedy on or before June 24, 2009. Final comments shall contain no more than ten (10) double-spaced and single-sided pages of textual material. All written submissions must conform with the provisions of section 201.8 of the Commission’s rules; any submissions that contain confidential business information must also conform with the requirements of section 201.6 of the Commission’s rules. The Commission’s rules authorize filing submissions with the Secretary by facsimile or electronic means only to the extent permitted by section 201.8 of the rules (see Handbook for Electronic Filing Procedures, https:// www.usitc.gov/secretary/ fed_reg_notices/rules/documents/ handbook_on_electronic_filing.pdf). Persons with questions regarding electronic filing should contact the Secretary (202–205–2000). In accordance with section 201.16(c) of the Commission’s rules, each document filed by a party to the investigation must be served on all other parties to the investigation (as identified by the service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. Remedy.—No separate hearing on the issue of remedy will be held. Those parties wishing to present arguments on the issue of remedy may do so orally at the hearing or in their prehearing or posthearing briefs or other written submissions. Authority: This investigation is being conducted under the authority of section 421 of the Trade Act of 1974; this notice is published pursuant to section 206.3 of the Commission’s rules. VerDate Nov<24>2008 17:48 Apr 28, 2009 Jkt 217001 By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. Issued: April 24, 2009. William R. Bishop, Acting Secretary to the Commission. [FR Doc. E9–9760 Filed 4–28–09; 8:45 am] a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance BILLING CODE P an opportunity for a hearing. Therefore, in accordance with Title 21 DEPARTMENT OF JUSTICE Code of Federal Regulations § 1301.34(a), this is notice that on Drug Enforcement Administration February 20, 2009, Meridian Medical Technologies, 2555 Hermelin Drive, St. Importer of Controlled Substances; Louis, Missouri 63144, made Notice of Application application by renewal to the Drug This is notice that on March 10, 2009, Enforcement Administration (DEA) to Penick Corporation, 33 Industrial Park be registered as an importer of Road, Pennsville, New Jersey 08070, Morphine (9300), a basic class of made application by renewal to the controlled substance listed in schedule Drug Enforcement Administration II. (DEA) for registration as an importer of The company plans to import the basic classes of controlled products for research experimentation substances listed in schedule II. or clinical use and analytical testing. Drug Schedule Any bulk manufacturer who is presently, or is applying to be, Coca Leaves (9040) ..................... II Raw Opium (9600) ....................... II registered with DEA to manufacture Poppy Straw (9650) ...................... II such basic class of controlled substance may file comments or objections to the Concentrate of Poppy Straw (9670) ........................................ II issuance of the proposed registration and may, at the same time, file a written The company plans to import the request for a hearing on such listed controlled substances to application pursuant to 21 CFR 1301.43 manufacture bulk controlled substance and in such form as prescribed by 21 intermediates for sale to its customers. CFR 1316.47. As noted in a previous notice Any such comments or objections published in the Federal Register on being sent via regular mail should be September 23, 1975 (40 FR 43745), all addressed, in quintuplicate, to the Drug applicants for registration to import a Enforcement Administration, Office of basic class of any controlled substances in schedule I or II are, and will continue Diversion Control, Federal Register to be, required to demonstrate to the Representative (ODL), 8701 Morrissette Deputy Assistant Administrator, Office Drive, Springfield, Virginia 22152; and of Diversion Control, Drug Enforcement must be filed no later than May 29, Administration, that the requirements 2009. for such registration pursuant to 21 This procedure is to be conducted U.S.C. 958(a); 21 U.S.C. 823(a); and 21 simultaneously with, and independent CFR 1301.34(b), (c), (d), (e), and (f) are of, the procedures described in 21 CFR satisfied. 1301.34(b), (c), (d), (e), and (f). As noted Dated: April 17, 2009. in a previous notice published in the Joseph T. Rannazzisi, Federal Register on September 23, 1975 Deputy Assistant Administrator, Office of (40 FR 43745–46), all applicants for Diversion Control, Drug Enforcement registration to import a basic class of Administration. any controlled substance listed in [FR Doc. E9–9778 Filed 4–28–09; 8:45 am] schedule I or II are, and will continue BILLING CODE 4410–09–P to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement DEPARTMENT OF JUSTICE Administration, that the requirements for such registration pursuant to 21 Drug Enforcement Administration U.S.C. 958(a), 21 USC § 823(a), and 21 Importer of Controlled Substances; CFR 1301.34(b), (c), (d), (e), and (f) are Notice of Application satisfied. Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Page 19594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9778]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    This is notice that on March 10, 2009, Penick Corporation, 33 
Industrial Park Road, Pennsville, New Jersey 08070, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the basic classes of controlled substances listed in 
schedule II.

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Coca Leaves (9040)...........................................         II
Raw Opium (9600).............................................         II
Poppy Straw (9650)...........................................         II
Concentrate of Poppy Straw (9670)............................         II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
manufacture bulk controlled substance intermediates for sale to its 
customers.
    As noted in a previous notice published in the Federal Register on 
September 23, 1975 (40 FR 43745), all applicants for registration to 
import a basic class of any controlled substances in schedule I or II 
are, and will continue to be, required to demonstrate to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, that the requirements for such registration pursuant to 
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), 
(e), and (f) are satisfied.

    Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-9778 Filed 4-28-09; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.